Paradigm ambulatory insulin infusion pumps, manufactured by Medtronic
May 24, 2013 No CommentsMedtronic have identified a risk of compromised insulin therapy when using Paradigm ambulatory insulin infusion pumps, which may lead to
Medtronic have identified a risk of compromised insulin therapy when using Paradigm ambulatory insulin infusion pumps, which may lead to
Insulet Corporation PODD +1.30% As the incidence of severe insulin resistance continues to rise, more and more people with type
The clinical value of regular self-monitoring of blood glucose (SMBG) in people with type 2 diabetes remains controversial. Some studies
When it comes to insulin pumps vs. shots , a lot of message board space on the web is being
Developers of a pill bottle that wirelessly transmits data, measures medication and sends patient reminders have emerged as grand prize
Diaz has an insulin pump. Here she tells us how it works, and why she feels it has improved her
The fact that the NHS is not providing insulin pumps to enough people with Type 1 diabetes – compared to
Glooko, Inc., makers of an innovative mobile solution for diabetes management, has received FDA 510(k) clearance for its next-gen Glooko System
As a child, I was lucky enough to attend diabetes camp. It became my second home summer after summer. It
Being a kid with type 1 diabetes isn’t easy. The daily realities of diabetes management, for both the child and
We go inside Blueprint Health, a health-tech accelerator in New York City, to meet some of the entrepreneurs working to
The California company that makes continuous glucose monitors (CGMs) is creating what it calls the Dexcom Share, a sort of docking
Duane DeSisto - President & CEO Thanks, Brian. Good afternoon everyone and thank you for joining us today. 2013 is off
If you’ve experienced problems with a medical device (or even with medications and vaccines) the Food and Drug Administration wants
These days, very few of us have a phone that is simply black or silver or white. Instead, our phones
No matter how much technology we throw at it, the diabetes epidemic just won’t budge. Today, 8.3% of the U.S.
Insulet Corporation, the company behind the OmniPod tubeless Insulin Management System, announced it has entered into an agreement with Eli Lilly
I love my DexCom CGM. I’m thankful to be in a position to own one. For me, CGM is the
Diabetes Australia-Victoria invites you to be a part of our second webinar for 2013 on insulin pumping. Time: Contact :
As China’s healthcare market explodes, a new report from PricewaterhouseCoopers names telemedicine…InspireMD gets a Wall Street boost after announcing FDA